Funding for this research was provided by:
Association France Alzheimer (AAP-SM2015-347)
Agence Nationale de la Recherche (ANR-10-AIHU-06)
Received: 7 February 2020
Accepted: 1 May 2020
First Online: 14 May 2020
Ethics approval and consent to participate
: The study was carried out in accordance with the ethical standards defined in the Declaration of Helsinki (2000). The INSIGHT-PreAD study was approved by the Ethics Committee of the Pitié Salpêtrière University Hospital.
: Not applicable
: MO Habert has received honoraria as expert for Blue Earth company.S Epelbaum received honoraria as consultant and/or speaker on behalf of Eli-Lilly, Roche, Biogen, Astelas Pharma, and GE Healthcare.B Dubois reports personal fees from Boehringer-Ingelheim, personal fees from Eli-Lilly, grants from Roche, and grants from Merck, outside the submitted work.The authors have no conflict of interest to report.